經緯輝開(300120.SZ):擬出售長沙宇順100%股權
格隆匯6月16日丨經緯輝開(300120.SZ)公佈,爲優化公司資產結構,提高資產運營效率,促進公司高質量發展,公司擬出售全資子公司長沙宇順100%股權,本次交易的受讓方爲華諾星空技術股份有限公司(以下簡稱“華諾星空”或“受讓方”)。
本次交易,華諾星空應向公司支付受讓長沙宇順100%股權的價款爲1.12億元;股權轉讓款全部支付完畢後十個工作日內,由長沙宇順向新輝開支付應付款項2796.32萬元,即華諾星空與長沙宇順合計向公司及新輝開支付1.4億元。交易完成後,公司將不再持有長沙宇順的股權,其將不再納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.